Healthcare Capital Corp Warrants 2020- on Healthcare Capital HCCCW 深 滬
交易中 09-20 10:32:59 美东时间
0.49
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.49
- 總市值 1684.38万
- 52周最高 1.15
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.18
- 委 比 0.00%
- 總股本 3437.50万
- 歷史最高 1.15
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.18
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tenax Therapeutics Secures $100M In Oversubscribed Private Placement Financing
The private placement was led by new investor BVF Partners LP, with participation from other new investors, including Venrock Healthcare Capital Partners, Vivo Capital, Janus Henderson Investors, a large investment
08-06 19:16
CASI Pharmaceuticals announces $15M private placement financing
CASI Pharmaceuticals (NASDAQ:CASI) on Wednesday said it has entered into securities purchase agreements with certain investors for a private investment in public equity financing that is expected to r...
06-27 04:15
Behavioral Health-Focused Investment Bank in Dallas Welcomes New Managing Director
DALLAS, June 11, 2024 /PRNewswire/ -- Healthcare Capital Advisors ("HCA"), a ne...
06-11 20:31
Syra Health to Participate in Healthcare Capital Markets & Innovation Summit in Columbus, OH
CARMEL, Ind., May 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company that is powering better health by providing mean...
05-30 04:30
快讯 | Lycia Therapeutics宣布完成1.066亿美元的超额认购C轮融资
Lycia Therapeutics是一家美国细胞表面靶点蛋白降解疗法开发商，致力于开发利用靶向溶酶体的嵌合体技术，Lycia公司开发的LYTAC技术，有望拓展...
05-14 17:14
Century Therapeutics获得战略投资
美国肿瘤治疗服务提供商Century Therapeutics（简称：Century）于2024年4月12日获得战略投资。本轮融资由Adage Capital...
04-12 14:01
ORIC Pharmaceuticals Announces $125M Private Placement Of ~12.5M Shares At $10.00/Share
Funding from new and existing investors including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), and Nextech Pro forma cash
01-22 21:34
Spyre Therapeutics Announces $180 Million Private Placement
WALTHAM, Mass., Dec. 7, 2023 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre") (NASDAQ: SYRE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to tr...
2023-12-08 07:20
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1
2023-08-26 01:56
